BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
MDM2
,
Apoptosis
,
Hepatitis
,
Leukocyte
,
Autoimmunity
,
Fluoxetine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bcl-w
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Frontal cortex
Cerebellar hemisphere
Whole brain
Thalamus lateral nuclei
Frontal lobe
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Rhinitis
Infection by Schistosoma
Disease due to Orthopoxvirus
Injury of external ear
Disease due to Adenovirus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
idebenone
Hexachlorophene
manganese chloride
butenafine
glimepiride
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR135B
PCDH11X
TSC1
PPOX
PCDH11X
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT…
BCL-W has a fundamental role in B cell survival and lymphomagenesis.
Oxidative Modification of miR-184 Enables It to Target Bcl-xL and Bcl-w.
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL.
BCL-W makes only minor contributions to MYC-driven lymphoma development.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T C…
2157GCCC:Phase 1 of Calaspargase Pegol-mknl w/ Cytarabine and Idarubicin in Newly Dx AML
A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors
APG-1252 in Patients With SCLC or Advanced Solid Tumors
A Study of APG-1252 in Patients With SCLC or Other Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ